FDA Clearance Tracker · P070022-S026
ADIANA PERMANENT CONTRACEPTION SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 9, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Feb 9, 2012
Approved
Time to decision
23 days
Received Jan 17, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P070022-S026
- Device name
- ADIANA PERMANENT CONTRACEPTION SYSTEM
- Applicant
- Hologic, Inc.
- Applicant location
- Malborough, MA
- Received
- Jan 17, 2012
- Decided
- Feb 9, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P070022
Device type
- Device class
- Class III
- Regulation
- 21 CFR 884.5380
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT HOLOGIC COSTA RICA SA. IN ALAJUELA, COSTA RICA.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
K262792 · Decided Aug 12, 2026 · 6 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
K253634 · Decided Jun 17, 2026 · 210 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.